MyAverix Finance
US · Healthcare
Oruka Therapeutics, Inc. (ORKA)
Biotechnology
Oruka Therapeutics, Inc. (ORKA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ORKA
Oruka Therapeutics, Inc. (ORKA) — FAQ
What is ORKA's P/E ratio?
The price-to-earnings (P/E) ratio for Oruka Therapeutics, Inc. (ORKA) is 18.00 (data as of 2026-03-24).
Does Oruka Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Oruka Therapeutics, Inc. (ORKA). Check the MyAverix Finance app for the latest dividend data.
What sector is Oruka Therapeutics, Inc. in?
Oruka Therapeutics, Inc. (ORKA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ORKA listed on?
ORKA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.